Patents by Inventor Daniel Lawson

Daniel Lawson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Kit for protein S functional assay
    Patent number: 8334108
    Abstract: The invention relates generally to a new functional protein S assay and kit that is based on the ability of endogenous protein S to prolong clotting time. In the assay procedure, a test plasma sample is diluted with protein S deficient plasma, followed by the addition of purified or recombinant tissue factor (pTF or rTF), purified natural or synthetic phospholipid (pPL or sPL) and activated protein C (APC) or protein C activator (PCA). The clotting time is then measured and compared to a standard curve or a normal control.
    Type: Grant
    Filed: November 19, 2008
    Date of Patent: December 18, 2012
    Assignee: Instrumentation Laboratory Company
    Inventors: Yong Dai, Biqing Ye, Kui Chen, Pau Bruguera, Daniel Lawson, Shamay Tang
  • SYSTEMS AND METHODS FOR FORMING A PROTECTIVE PAD
    Publication number: 20110256346
    Abstract: A protective pad configuration is provided that includes a corrugated energy dispersing plate disposed between an upper and a lower foam member. The corrugated energy dispersing plate provides stiffness along a first direction and flexibility in a second direction to enable pad design that maximizes both athlete protection and mobility.
    Type: Application
    Filed: March 31, 2011
    Publication date: October 20, 2011
    Applicant: XOATHLETICS, LLC
    Inventors: Anton Edis Bowden, Robert David Campbell, Russell Dibb, Brandon Doyle, Daniel Lawson, Chad Pharo
  • Protein S functional assay
    Publication number: 20050095662
    Abstract: The invention relates generally to a new functional protein S assay and kit that is based on the ability of endogenous protein S to prolong clotting time. In the assay procedure, a test plasma sample is diluted with protein S deficient plasma, followed by the addition of purified or recombinant tissue factor (pTF or rTF), purified natural or synthetic phospholipid (pPL or sPL) and activated protein C (APC) or protein C activator (PCA). The clotting time is then measured and compared to a standard curve or a normal control.
    Type: Application
    Filed: December 15, 2004
    Publication date: May 5, 2005
    Applicant: Instrumentation Laboratory Company
    Inventors: Yong Dai, Biqing Ye, Kui Chen, Pau Bruguera, Daniel Lawson, ShaMay Tang